 Olanzapine o-lan-zah-peen is a medication that has been approved by the Food and Drug Administration FDA for the treatment of patients with schizophrenia and or bipolar disorder. The trade name for this drug is Zyprexa. Olanzapine has not been approved by the FDA for the prevention of migraine and is experimental for the purposes of this research study. 